3.2002

2.43% -0.0898

Relay Therapeutics Inc (RLAY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RLAY? Forum Prognose

Schlusskurs vom Vortag:

$3.29

Offen:

$3.31

24-Stunden-Volumen:

1.32M

Relative Volume:

0.60

Marktkapitalisierung:

$545.56M

Einnahmen:

$25.55M

Nettoeinkommen (Verlust:

$-341.97M

KGV:

-1.1429

EPS:

-2.8

Netto-Cashflow:

$-304.44M

1W Leistung:

+0.31%

1M Leistung:

+28.92%

6M Leistung:

-45.03%

1J Leistung:

-54.66%

1-Tages-Spanne:

$3.20

$3.365

1-Wochen-Bereich:

$2.96

$3.47

52-Wochen-Spanne:

$1.775

$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Firmenname

Relay Therapeutics Inc

Sektor

Healthcare (1153)

Branche

Biotechnology (662)

Telefon

617-370-8837

Adresse

399 BINNEY STREET, CAMBRIDGE

Mitarbeiter

261

Twitter

Nächster Verdiensttermin

2025-02-21

Neueste SEC-Einreichungen

RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RLAY Relay Therapeutics Inc	3.205	545.56M	25.55M	-341.97M	-304.44M	-2.80
VRTX Vertex Pharmaceuticals Inc	501.37	126.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	609.84	65.06B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	650.98	37.54B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	259.73	32.56B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	256.27	26.40B	3.81B	-644.79M	-669.77M	-6.24

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-17	Eingeleitet	Wells Fargo	Equal Weight
2024-09-10	Fortgesetzt	Goldman	Buy
2024-09-10	Hochstufung	Jefferies	Hold → Buy
2024-09-10	Herabstufung	Oppenheimer	Outperform → Perform
2024-05-10	Hochstufung	Barclays	Equal Weight → Overweight
2023-04-20	Hochstufung	Jefferies	Underperform → Hold
2023-04-19	Hochstufung	Raymond James	Outperform → Strong Buy
2023-04-13	Eingeleitet	Raymond James	Outperform
2023-02-03	Eingeleitet	Oppenheimer	Outperform
2022-09-30	Eingeleitet	Barclays	Equal Weight
2022-09-02	Eingeleitet	Stifel	Buy
2022-06-06	Eingeleitet	Jefferies	Underperform
2022-02-01	Eingeleitet	Berenberg	Buy
2021-07-21	Eingeleitet	BofA Securities	Buy
2020-12-15	Bestätigt	H.C. Wainwright	Buy
2020-12-08	Eingeleitet	JMP Securities	Mkt Outperform
2020-11-05	Eingeleitet	H.C. Wainwright	Buy
2020-08-10	Eingeleitet	Cowen	Outperform
2020-08-10	Eingeleitet	Goldman	Buy
2020-08-10	Eingeleitet	Guggenheim	Buy
2020-08-10	Eingeleitet	JP Morgan	Neutral

Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

08:01 AM

There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister

08:01 AM

May 01, 2025

why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com

May 01, 2025

LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 01, 2025

Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa

May 01, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa

May 01, 2025

Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa

May 01, 2025

Apr 30, 2025

Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise

Apr 30, 2025

Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView

Apr 30, 2025

Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News

Apr 30, 2025

Trading Day Review: Relay Therapeutics Inc (RLAY) Loses Momentum, Closing at 3.10 - DWinneX

Apr 30, 2025

Relay Therapeutics Inc: Weathering Stock Market Storms with 528.51M Market Cap - investchronicle.com

Apr 30, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Legal & General Group Plc - Defense World

Apr 30, 2025

Apr 29, 2025

RLAY (Relay Therapeutics Inc) may reap gains as insiders became active recently - knoxdaily.com

Apr 29, 2025